Skip to main content
. Author manuscript; available in PMC: 2015 Sep 9.
Published in final edited form as: Pediatr Blood Cancer. 2013 Jul 2;60(11):1766–1771. doi: 10.1002/pbc.24667

TABLE III.

Slipped Capital Femoral Epiphysis Incidence Rates in Cancer Survivors Treated With Recombinant Human Growth Hormone for Radiation-Induced Growth Hormone Deficiency After Total Body Irradiation Compared to Patients With Idiopathic Growth Hormone Deficiency

No. patients No. SCFE Person yrs Incidence rate (per 1,000 person yrs) Incidence rate ratio
TBI 57 10 279 35.9 (95% CI 20.0, 70.0) 211.2 (95% CI 53.7, 287.4)
Idiopathic GHDa 22,696 12 71,570 0.17 —

GHD, refers to growth hormone deficiency; Person yrs, person years on rhGH treatment.

a

National cooperative growth study May 2009 Pediatric Endocrinology Lawson Wilkins meeting reported results for subjects treated with recombinant human growth hormone (rhGH) for idiopathic growth hormone deficiency.